Human PRG2 (Bone Marrow Proteoglycan) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-04836P
SDS-PAGE analysis of Human PRG2 (Bone Marrow Proteoglycan) - Recombinant Protein, CAT# BLT-04836P, showing >95% purity under 15% SDS-PAGE (Reduced)
Human PRG2 (Bone Marrow Proteoglycan) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-04836P
Regular price
$59500
$595.00
Sale price$41500
$415.00Save $180
/
Quantity Pricing
| Pack Size | Price (USD) |
|---|---|
| 500 µg | $962.50 Original price: |
| 1 mg | $1,746.00 Original price: |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human Bone Marrow Proteoglycan/BMPG (PRG2) Protein |
| Product Overview | This recombinant human Bone Marrow Proteoglycan/BMPG (PRG2) protein includes amino acids 17-222aa of the target gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id | P13727 |
| Recommended Name | Bone marrow proteoglycan |
| Gene Name | PRG2 |
| Synonyms | Bone Marrow Proteoglycan; BMPG; Proteoglycan 2; Eosinophil Granule Major Basic Protein; EMBP; MBP; P |
| Species | Human |
| Predicted Molecular Mass | 24.6 kDa |
| Expression System | Mammalian Cell |
| Expression Range | 17-222aa |
| Tag | C-6His |
| Purity | >95% |
| Formulation | Lyophilized |
| Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications | Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area | Immunology |
| Target Function | Cytotoxin and helminthotoxin. Also induces non-cytolytic histamine release from human basophils. Involved in antiparasitic defense mechanisms and immune hypersensitivity reactions. The proform acts as a proteinase inhibitor, reducing the activity of PAPPA. |
| Subcellular Location | [Bone marrow proteoglycan]: Secreted. Note=The proform is secreted.; [Eosinophil granule major basic protein]: Cytoplasmic vesicle, secretory vesicle. Note=The proform is secreted. The mature protein is found in the matrix of the eosinophil's large specific granule (crystalloid core). |
| Tissue Specificity | High levels of the proform in placenta and pregnancy serum; in placenta, localized to X cells of septa and anchoring villi. Lower levels in a variety of other tissues including kidney, myometrium, endometrium, ovaries, breast, prostate, bone marrow and co |
